Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 484

    1.

    Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.

    Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C, Mitchell G.

    Breast Cancer Res. 2008;10(6):216. Epub 2008 Nov 28. Review.

    PMID:
    19090970
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.

    Pasacreta JV.

    Cancer Invest. 2003;21(4):588-623. Review.

    PMID:
    14533449
    [PubMed - indexed for MEDLINE]
    3.

    Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer.

    Hopwood P.

    Curr Opin Oncol. 2005 Jul;17(4):340-4. Review.

    PMID:
    15933464
    [PubMed - indexed for MEDLINE]
    4.

    Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.

    Schwartz MD, Lerman C, Brogan B, Peshkin BN, Isaacs C, DeMarco T, Halbert CH, Pennanen M, Finch C.

    Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1003-7.

    PMID:
    15824179
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    A literature review of the psychological impact of genetic testing on breast cancer patients.

    Schlich-Bakker KJ, ten Kroode HF, Ausems MG.

    Patient Educ Couns. 2006 Jul;62(1):13-20. Epub 2005 Oct 19. Review.

    PMID:
    16242293
    [PubMed - indexed for MEDLINE]
    6.

    Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review.

    Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM.

    Med J Aust. 2003 Jan 20;178(2):77-81. Review.

    PMID:
    12526728
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.

    Arver B, Haegermark A, Platten U, Lindblom A, Brandberg Y.

    Fam Cancer. 2004;3(2):109-16.

    PMID:
    15340261
    [PubMed - indexed for MEDLINE]
    8.

    Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).

    Juan AS, Wakefield CE, Kasparian NA, Kirk J, Tyler J, Tucker K.

    Genet Test. 2008 Dec;12(4):523-32.

    PMID:
    19072564
    [PubMed - indexed for MEDLINE]
    9.

    Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.

    Hutson SP.

    Oncol Nurs Forum. 2003 Mar-Apr;30(2):241-6. Review.

    PMID:
    12692658
    [PubMed - indexed for MEDLINE]
    10.

    Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.

    Silva E, Lynch H.

    Breast J. 2006 May-Jun;12(3):280-1; author reply 282-4. No abstract available.

    PMID:
    16684334
    [PubMed - indexed for MEDLINE]
    11.

    Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.

    Matloff ET, Moyer A, Shannon KM, Niendorf KB, Col NF.

    J Womens Health (Larchmt). 2006 Sep;15(7):843-56.

    PMID:
    16999640
    [PubMed - indexed for MEDLINE]
    12.

    Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.

    Hopwood P, Keeling F, Long A, Pool C, Evans G, Howell A.

    Psychooncology. 1998 Sep-Oct;7(5):402-12.

    PMID:
    9809331
    [PubMed - indexed for MEDLINE]
    13.

    Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.

    Bowen DJ, Burke W, Yasui Y, McTiernan A, McLeran D.

    Genet Med. 2002 Sep-Oct;4(5):359-65.

    PMID:
    12394349
    [PubMed - indexed for MEDLINE]
    15.

    Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.

    Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA.

    Arch Surg. 2003 Dec;138(12):1323-8; discussion 1329.

    PMID:
    14662532
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.

    Decruyenaere M, Evers-Kiebooms G, Denayer L, Welkenhuysen M, Claes E, Legius E, Demyttenaere K.

    Eur J Hum Genet. 2000 Feb;8(2):130-6.

    PMID:
    10757645
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review.

    Meiser B, Halliday JL.

    Soc Sci Med. 2002 May;54(10):1463-70.

    PMID:
    12061481
    [PubMed - indexed for MEDLINE]
    18.

    Predisposition testing for inherited breast cancer.

    Cummings S, Olopade O.

    Oncology (Williston Park). 1998 Aug;12(8):1227-41; discussion 1241-2. Review.

    PMID:
    11236312
    [PubMed - indexed for MEDLINE]
    19.

    Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer.

    Kash KM, Ortega-Verdejo K, Dabney MK, Holland JC, Miller DG, Osborne MP.

    Semin Surg Oncol. 2000 Jun;18(4):333-8.

    PMID:
    10805955
    [PubMed - indexed for MEDLINE]
    20.

    Genetic counseling and testing for breast cancer risk in African Americans.

    Halbert CH.

    LDI Issue Brief. 2006 Sep;12(1):1-4.

    PMID:
    17302016
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk